Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Implementation of Medicaid Community Engagement requirements Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2026 · third_quarter · Q3
Blood and plasma safety and awareness Bleeding disorders awareness Fostering Effective Diagnosis and Treatment for Underserved Populations (FED UP) with Bleeding Disorders Act (H.R. 8794)
Implementation of H.R. 1, One Big Beautiful Bill Act Comment letter in response to CMS IFR re Medicaid Program: Community Engagement Requirement for Certain Individuals Comment letter in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard Sign on letter re No Surprises Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs
Source: Senate LDA
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare: comments on proposed HOPPS rule (CMS-1850-P) Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements: comments on Medicaid community engagement IFR (CMS-2454-IFC)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Comment letter in response to CMS IFR re Medicaid Program: Community Engagement Requirement for Certain Individuals Comment letter in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard Sign on letter re No Surprises Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Implementation of Medicaid Community Engagement requirements Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid: comments on Medicaid community engagement IFR (CMS-2454-IFC)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
To advance policy priorities that will break the gridlock.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
To advance policy priorities that will break the gridlock.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Comment letter in response to CMS IFR re Medicaid Program: Community Engagement Requirement for Certain Individuals Comment letter in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard Sign on letter re No Surprises Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs
FED UP with Bleeding Disorders Act of 2026
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Blood and plasma safety and awareness Bleeding disorders awareness Fostering Effective Diagnosis and Treatment for Underserved Populations (FED UP) with Bleeding Disorders Act (H.R. 8794)
FED UP with Bleeding Disorders Act of 2026
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Blood and plasma safety and awareness Bleeding disorders awareness Fostering Effective Diagnosis and Treatment for Underserved Populations (FED UP) with Bleeding Disorders Act (H.R. 8794)
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Comment letter in response to CMS IFR re Medicaid Program: Community Engagement Requirement for Certain Individuals Comment letter in response to Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard Sign on letter re No Surprises Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P)
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 1796/S. 735)
To advance policy priorities that will break the gridlock.
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
To advance policy priorities that will break the gridlock.
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
Health Care Affordability Act of 2025
Client: THE HEMOPHILIA ALLIANCE · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
Health Care Affordability Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 1796/S. 735)
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Securing Guam’s Shores Reimbursement Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
Health Care Affordability Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
Health Care Affordability Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Definition of 'Employer'-Association Health Plans".
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models
Safe Step Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Safe Step Act (HR 2630/ S. 652) Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) Congressional sign-on letter to HHS/Treasury/Labor asking them to release the promised rule closing the EHB loophole for ERISA plans
Medicaid VBPs for Patients Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
NIH Clinical Trial Diversity Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter in response to Congressional Framework on Reforming the National Institutes of Health Letter in response to FDA Draft Guidance on Diversity Action Plans
NIH Clinical Trial Diversity Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)
Menstrual Equity For All Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
Creating Hope Reauthorization Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384) Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023)
Creating Hope Reauthorization Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384)
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Safe Step Act (HR 2630/ S. 652) Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) Congressional sign-on letter to HHS/Treasury/Labor asking them to release the promised rule closing the EHB loophole for ERISA plans
HELP Copays Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models
Health Care Affordability Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Safe Step Act (HR 2630/ S. 652) Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) Congressional sign-on letter to HHS/Treasury/Labor asking them to release the promised rule closing the EHB loophole for ERISA plans
Health Care Affordability Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models
NIH Clinical Trial Diversity Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter in response to Congressional Framework on Reforming the National Institutes of Health Letter in response to FDA Draft Guidance on Diversity Action Plans
NIH Clinical Trial Diversity Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)
Accelerating Kids’ Access to Care Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
MVP Act
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
Health Care Affordability Act of 2024
Client: NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Firm: ARTEMIS POLICY GROUP LLC
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Implementation of Medicaid Community Engagement requirements Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid: comments on Medicaid community engagement IFR (CMS-2454-IFC)
Funding for federal hemophilia programs in FY27 House and Senate Labor-HHS Appropriations bills Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics Letter to CDC Director Erica Schwartz re Division of Blood Disorders & Public Health Genomics NIH FY27 appropriations
Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders Letter to OMB re Regulation for Federal Financial Assistance
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · third_quarter · Q3
Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics: Letter to CDC Director Erica Schwartz re Division of Blood Disorders & Public Health Genomics
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans: comments on essential health benefits review, RIN 0938-AW02 Policies related to co-pay accumulators and maximizers, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599 SUSTAIN 340B Act, S. 5244 Comments on Senate Finance Committee RFI on drug pricing
Issues related to reimbursement for hemophilia services and treatments in Medicare: comments on proposed HOPPS rule (CMS-1850-P) Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements: comments on Medicaid community engagement IFR (CMS-2454-IFC)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2026 · second_quarter · Q2
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft
Blood and plasma safety and awareness Bleeding disorders awareness Fostering Effective Diagnosis and Treatment for Underserved Populations (FED UP) with Bleeding Disorders Act (H.R. 8794)
Funding for federal hemophilia programs in FY27 House and Senate Labor-HHS Appropriations bills NIH FY27 appropriations
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Implementation of Medicaid Community Engagement requirements Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P)
Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of Medicaid Community Engagement requirements
Funding for federal hemophilia programs at CDC and HRSA for FY27 Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P). Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency 340B Drug Pricing Integrity and Affordability for Patients Act discussion draft SECURE 340B Act, HR 9599
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2026 · first_quarter · Q1
Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders
Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Blood and plasma safety and awareness Bleeding disorders awareness
Funding for federal hemophilia programs in FY26 and FY27 House and Senate Labor-HHS Appropriations bills NIH FY26 and FY27 appropriations
Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2026 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act
Issues related to participation in the 340B Drug Discount Program Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY26 Funding for federal hemophilia programs at CDC and HRSA for FY27
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2025 · fourth_quarter · Q4
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
Blood and plasma safety and awareness Bleeding disorders awareness
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · fourth_quarter · Q4
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834.
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2025 · third_quarter · Q3
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid
Blood and plasma safety and awareness Bleeding disorders awareness
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46. Protect patients from substandard and junk insurance products
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · third_quarter · Q3
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46.
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2025 · second_quarter · Q2
H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid
Blood and plasma safety and awareness Bleeding disorders awareness
H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · second_quarter · Q2
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid H.R. 1, One Big Beautiful Bill Act
H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2025 · first_quarter · Q1
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid
Blood and plasma safety and awareness Bleeding disorders awareness
Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)
THE HEMOPHILIA ALLIANCE via ARTEMIS POLICY GROUP LLC
2025 · first_quarter · Q1
Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid PBM Reform amendments to Medicaid and Medicare in Continuing Resolution draft legislation
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2024 · fourth_quarter · Q4
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 3884/S. 1852)
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Safe Step Act (HR 2630/ S. 652) Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program (CMS-9888-P) Congressional sign-on letter to HHS/Treasury/Labor asking them to release the promised rule closing the EHB loophole for ERISA plans
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) via ARTEMIS POLICY GROUP LLC
2024 · third_quarter · Q3
Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384) Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (CFPB-2024- 0023)
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Hemophilia research, prevention, surveillance and service programs and issues H.R. 3503/S. 1701 - NIH Clinical Trial Diversity Act Letter in response to Congressional Framework on Reforming the National Institutes of Health Letter in response to FDA Draft Guidance on Diversity Action Plans
Implementation of H.R. 1, One Big Beautiful Bill Act Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including the HELP Copays Act (S 864, HR 6423) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as Alternative Funding Programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Funding for federal hemophilia programs in FY26 House and Senate Labor-HHS Appropriations bills NIH FY26 appropriations
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Hemophilia research, prevention, surveillance and service programs and issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Funding for federal hemophilia programs in FY26 House and Senate Labor-HHS Appropriations bills NIH FY26 appropriations
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Hemophilia research, prevention, surveillance and service programs and issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation 340B ACCESS Act (HR 5256) - Draft House 340B reform legislation Polices related to PBMs and drug cost transparency
Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills NIH FY25 appropriations
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Hemophilia research, prevention, surveillance and service programs and issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
Issues related to participation in the 340B Drug Discount Program SUSTAIN 340B ACT - Draft Senate 340B reform legislation Polices related to PBMs and drug cost transparency
Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics Funding for federal hemophilia programs at CDC and HRSA for FY25 and FY26
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills NIH FY25 appropriations
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Hemophilia research, prevention, surveillance and service programs and issues Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 1796/S. 735)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program
Blood and plasma safety and awareness Bleeding disorders awareness Securing Equal Access to Research, Care, and Health (SEARCH) Act Creating Hope Reauthorization Act of 2024 (HR 7384)
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Providing Realistic Opportunity to Equal and Comparable Treatment (PROTECT) for Rare Act (H.R. 6094) The Menstrual Equity for All Act (H.R. 3646) Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.4204) Accelerating Kids Access to Care Act (S. 2372)
Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid Comments in response to CY 2025 Medicare Physician Fee Schedule Comments in response to CY 2025 Medicare HOPPS proposed rule
Implementation of the Affordable Care Act The HELP Copays Act (HR 830) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Issues related to 1332 state innovation waivers H.J. Res. 181, Congressional Review Act resolution to stop the Biden-Harris rule limiting access to Association Health Plans (AHPs) Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) AIMED Alliance Citizens Petition re drug importation and alternative payment models
FY25 House and Senate Labor-HHS Appropriations bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of